HighTide Therapeutics, Inc. 君聖泰醫藥

Pay for financial year ended 2023-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Hung, Tak Wai (SFC:BQQ641) 孔德偉 INED 4 4
2 Jiang, Feng (1979) 江峰 NED
3 Li, Jin (1965) 李靖 INED 4 4
4 Li, Li (Shenzhen Hepalink) 李鋰 NED
5 Liu, Liping (1969) 劉利平 Ch, CEO, Fdr 3,538 38 11,087 14,663
6 Ma, Lixiong (1974) 馬立雄 NED 8,902 8,902
7 Tan, Bo (1973) 譚擘 INED 4 4
8 Yang, Feng (HighTide Therapeutics) 楊鋒 NED 174 174
9 Yu, Meng (1981) 于萌 ED 1,238 111 9,480 10,829
10 Zhu, Xun (1958) 朱迅 NED 496 1,345 1,841
Total 12 5,272 0 149 30,988 36,421

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 12 5,272 0 149 30,988 36,421 Report
Total 12 5,272 0 149 30,988 36,421

Want to see more years here? volunteer to be a Webb-site editor and add the data from annual reports!


Sign up for our free newsletter

Recommend Webb-site to a friend

Copyright & disclaimer, Privacy policy

Back to top